Familial case of congenital hyperinsulinism associated with mutation in the GLUD1 gene
https://doi.org/10.14341/probl2017633195-200
Abstract
Congenital hyperinsulinism (CHI) is a rare hereditary disease characterized by hypoglycemia in children during the first year of life. Late diagnosis and inadequate therapy may result in severe neurological complications. Mutations in the GLUD1 gene that encodes glutamate dehydrogenase are one of the causes of CHI. This form of CHI is characterized by protein-induced hyperinsulinemic hypoglycemia and hyperammonemia in patients. Diagnosing can be challenging because hyperinsulinemic hypoglycemia cannot be detected using the conventional fasting glucose test. Extensive examination including the protein load test is needed to refine diagnosis. We report a familial case where the mother and two daughters were diagnosed with CHI and had a mutation in the catalytic domain of the GLUD1 gene. The clinical presentation, the laboratory data, the outcome of therapy, and the dynamic follow up data for the patients are presented.
About the Authors
Maria A. MelikyanEndocrinology Research Centre
Russian Federation
MD, PhD
Anatoly N. Tiulpakov
Endocrinology Research Centre
Russian Federation
MD, PhD, Professor
Maria A. Kareva
Endocrinology Research Centre
Russian Federation
MD, PhD
References
1. Hussain K, Blankenstein O, De Lonlay P, Christesen HT. Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Arch Dis Child. 2007;92(7):568-570. doi: 10.1136/adc.2006.115543
2. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2000;82(2):F79-F86. PMC1721059
3. Thomas P, Cote G, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268(5209):426-429. doi: 10.1126/science.7716548
4. Thomas P. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet. 1996;5(11):1809-1812. doi: 10.1093/hmg/5.11.1809
5. Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998;338(19):1352-1357. doi: 10.1056/NEJM199805073381904
6. Weinzimer SA, Stanley CA, Berry GT, et al. A syndrome of congenital hyperinsulinism and hyperammonemia. J Pediatr. 1997;130(4):661-664. doi: 10.1016/s0022-3476(97)70256-7
7. Hudson RC, Daniel RM. l-glutamate dehydrogenases: Distribution, properties and mechanism. Comparative Biochemistry and Physiology Part B: Comparative Biochemistry. 1993;106(4):767-792. doi: 10.1016/0305-0491(93)90031-y
8. MacMullen C, Fang J, Hsu BYL, et al. Hyperinsulinism/Hyperammonemia Syndrome in Children with Regulatory Mutations in the Inhibitory Guanosine Triphosphate-Binding Domain of Glutamate Dehydrogenase 1. J Clin Endocr Metab. 2001;86(4):1782-1787. doi: 10.1210/jcem.86.4.7414
9. Stanley CA, Fang J, Kutyna K, et al. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes. 2000;49(4):667-673. doi: 10.2337/diabetes.49.4.667
10. Yorifuji T, Muroi J, Uematsu A, et al. Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics. Hum Genet. 1999;104(6):476-479. doi: 10.1007/s004390050990
11. Stanley CA. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab. 2004;81:Suppl 1:S45-S51. doi: 10.1016/j.ymgme.2003.10.013
12. Kapoor RR, Flanagan SE, Fulton P, et al. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations. Eur J Endocrinol. 2009;161(5):731-735. doi: 10.1530/EJE-09-0615
13. Kapoor RR, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab. 2009;5(2):101-112. doi: 10.1038/ncpendmet1046
14. Bahi-Buisson N, El Sabbagh S, Soufflet C, et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure. 2008;17(7):658-664. doi: 10.1016/j.seizure.2008.01.005
15. Bahi-Buisson N, Roze E, Dionisi C, et al. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol. 2008;50(12):945-949. doi: 10.1111/j.1469-8749.2008.03114.x
16. Palladino AA, Stanley CA. The hyperinsulinism/hyperammonemia syndrome. Rev Endocr Metab Disord. 2010;11(3):171-178. doi: 10.1007/s11154-010-9146-0
17. Li C, Li M, Chen P, et al. Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site. J Biol Chem. 2011;286(39):34164-34174. doi: 10.1074/jbc.M111.268599
18. Li M, Smith CJ, Walker MT, Smith TJ. Novel inhibitors complexed with glutamate dehydrogenase: allosteric regulation by control of protein dynamics. J Biol Chem. 2009;284(34):22988-23000. doi: 10.1074/jbc.M109.020222
19. Santer R, Kinner M, Superti-Furga A, et al. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet. 2001;108(1):66-71. doi: 10.1007/s004390000432
Supplementary files
|
1. рисунок 1 | |
Subject | ||
Type | Other | |
View
(7KB)
|
Indexing metadata ▾ |
|
2. Рисунок. Родословная пациентов. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(5KB)
|
Indexing metadata ▾ |
Review
For citations:
Melikyan M.A., Tiulpakov A.N., Kareva M.A. Familial case of congenital hyperinsulinism associated with mutation in the GLUD1 gene. Problems of Endocrinology. 2017;63(3):195-200. https://doi.org/10.14341/probl2017633195-200

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).